Yüklüyor......

Ibrexafungerp Demonstrates In Vitro Activity against Fluconazole-Resistant Candida auris and In Vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis

Candida auris is an emerging pathogen that has rapidly spread to many countries on multiple continents. Invasive infections caused by this species are associated with significant mortality, and treatment options are limited due to antifungal resistance. Ibrexafungerp is the first-in-class member of...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Antimicrob Agents Chemother
Asıl Yazarlar: Wiederhold, Nathan P., Najvar, Laura K., Olivo, Marcos, Morris, Kelsey N., Patterson, Hoja P., Catano, Gabriel, Patterson, Thomas F.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2021
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315906/
https://ncbi.nlm.nih.gov/pubmed/33753333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02694-20
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!